4,4′-Diacetylbiphenyl

We are 4,4′-Diacetylbiphenyl CAS:787-69-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   4,4'-Diacetylbiphenyl
CAS.NO:787-69-9
Synonyms:1-[4-(4-acetylphenyl)phenyl]ethanone

Molecular Formula: C16H14O2
Molecular Weight:238.28100

Physical and Chemical Properties:
Density: 1.094 g / cm3
Boiling point: 386.5ºC at 760 mmHg
Melting point: 193-195 ° C (lit.)
Flash point: 144.9 ± 17.9 ° C
Refractive index: 1.523

Specification:
Appearance: White crystalline powder
Purity:≥98.0%
Loss on drying:1.0%max

Packing:
25kg/drum. But we could also subpackage it according to our customers' requirements.Such as 1kg/bag, 5kg/bag, 10kg/bag,etc.
Storage:Store in a well-closed container away from moisture.
Application: 4,4'-Diacetylbiphenyl is a useful synthetic intermediate. It can be used to synthesize Daclatasvir which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).Intermediates of Daclatasvir CAS:1009119-64-5

Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.5-Bromo-2-pyridinecarbonitrile According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.77-63-4 In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.